VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $12,940 | +12.9% | 400,000 | 0.0% | 7.25% | +0.5% |
| Q4 2022 | $11,464 | -99.9% | 400,000 | 0.0% | 7.22% | -76.7% |
| Q3 2022 | $9,648,000 | +17.5% | 400,000 | +33.3% | 30.93% | +383.0% |
| Q2 2022 | $8,214,000 | -28.6% | 300,000 | 0.0% | 6.40% | -60.6% |
| Q1 2022 | $11,505,000 | -3.3% | 300,000 | -14.3% | 16.25% | +449.4% |
| Q2 2021 | $11,893,000 | -26.6% | 350,000 | -22.2% | 2.96% | -32.2% |
| Q4 2020 | $16,209,000 | -44.8% | 450,000 | -40.0% | 4.36% | -78.2% |
| Q3 2020 | $29,370,000 | -19.9% | 750,000 | -25.0% | 20.01% | -37.8% |
| Q2 2020 | $36,680,000 | +3568.0% | 1,000,000 | -95.7% | 32.20% | +1859.8% |
| Q1 2020 | $1,000,000 | – | 23,040,000 | – | 1.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |